Patents by Inventor Montserrat Andreu Corominas

Montserrat Andreu Corominas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lactic acid bacteria for coeliac disease
    Patent number: 10603342
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: March 31, 2020
    Assignee: Compagnie Gervais Danone
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • Functional peptides for obesity disorders
    Patent number: 9802990
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus. These peptides, extracts containing them and food products containing them are useful for the treatment and/or prevention of obesity and oxidative stress.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: October 31, 2017
    Assignee: DANONE, S.A.
    Inventors: Agusti Montserrat Carreras, Cristina Alvarez Fernandez, Montserrat Andreu Corominas, Daniel Ramón Vidal, Esther Bataller Leiva, Patricia Martorell Guerola, Salvador Genovés Martínez
  • Lactic Acid Bacteria for Coeliac Disease
    Publication number: 20170145379
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Application
    Filed: October 6, 2016
    Publication date: May 25, 2017
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • FUNCTIONAL PEPTIDES FOR OBESITY DISORDERS
    Publication number: 20160002303
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus.
    Type: Application
    Filed: February 19, 2013
    Publication date: January 7, 2016
    Applicant: DANONE, S.A.
    Inventors: Agusti MONTSERRAT CARRERAS, Cristina ALVAREZ FERNÁNDEZ, Montserrat ANDREU COROMINAS, Daniel RAMÓN VIDAL, Esther BATALLER LEIVA, Patricia MARTORELL GUEROLA, Salvador GENOVÉS MARTÍNEZ
  • Lactic Acid Bacteria for Coeliac Disease
    Publication number: 20130121976
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Application
    Filed: March 12, 2010
    Publication date: May 16, 2013
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva